Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar SanDieguito (< 20) Submitted: 9/7/2007 11:06:52 AM : Underperform Start Price: $12.87 ENZ Score: +80.00

US District Court ruled against this bio-chemical company in a patent infringement case brought by this company. The six disputed patents relate to the company's method and materials for detecting nucleic acid sequences. Lost $5

Featured Broker Partners


Advertisement